Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis

Journal of Neuroimaging

Volumn 25, Issue 4, 2015, Pages 595-599

  Paz Soldán, M Mateo ^a   Raman, Mekala R ^a   Gamez, Jeffrey D ^a   Lohrey, Anne K ^c   Chen, Yi ^c   Pirko, Istvan ^a   Johnson, Aaron J ^b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Atrophy; Disability; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISABILITY; DISEASE COURSE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTION; ROTAROD TEST; SPINAL CORD; SPINAL CORD ATROPHY; ANIMAL; ATROPHY; BRAIN; COMPARATIVE STUDY; MOVEMENT DISORDERS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICS;

ANIMALS; ATROPHY; BRAIN; DISEASE PROGRESSION; MAGNETIC RESONANCE IMAGING; MICE; MOVEMENT DISORDERS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; SPINAL CORD; STATISTICS AS TOPIC;

EID: 84937073544     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12250     Document Type: Article

References (28)

1. Prineas JW. Pathology of multiple sclerosis. In: Cook SD, ed. Handbook of Multiple Sclerosis. 3rd ed. New York: Marcel Dekker, 2001:289-324.
2. Stadelmann C, Albert M, Wegner C, et al. Cortical pathology in multiple sclerosis. Curr Opin Neurol 2008;21:229-34.
3. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008;31:247-69.
4. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157-62.
5. Kalkers NF, Ameziane N, Bot JC, et al. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol 2002;59:1572-6.
6. Oleszak EL, Chang JR, Friedman H, et al. Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 2004;17:174-207.
7. Denic A, Johnson AJ, Bieber AJ, et al. The relevance of animal models in multiple sclerosis research. Pathophysiology 2011;18:21-9.
8. Pirko I, Johnson AJ, Chen Y, et al. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 2011;54:802-6.
9. Johnson AJ, Upshaw J, Pavelko KD, et al. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J 2001;15:2760-2.
10. Tsunoda I, McCright IJ, Kuang LQ, et al. Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol 1997;56:1302-13.
11. MacKenzie-Graham A, Rinek GA, Avedisian A, et al. Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging. Neuroimage 2012;60:95-104.
12. Buenz EJ, Sauer BM, Lafrance-Corey RG, et al. Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am J Pathol 2009;175:668-84.
13. Howe CL, Lafrance-Corey RG, Sundsbak RS, et al. Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. J Neuroinflammation 2012;9:50.
14. Tsunoda I, Kurtz CI, Fujinami RS. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 1997;228:388-93.
15. Tsunoda I, Iwasaki Y, Terunuma H, et al. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus. Acta Neuropathol 1996;91:595-602.
16. Pirko I, Johnson AJ, Lohrey AK, et al. Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J Neurol Sci 2009;282:34-8.
17. Khalil M, Enzinger C, Langkammer C, et al. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009;15:1048-54.
18. Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol 2004;25:132-7.
19. Bitsch A, Kuhlmann T, Stadelmann C, et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 2001;49:793-6.
20. Pirko I, Nolan TK, Holland SK, et al. Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model. Radiology 2008;246:790-5.
21. McDole J, Suidan G, Boespflug E, et al. A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection. Hum Immunol 2008;69:805-10.
22. McGavern DB, Murray PD, Rodriguez M. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. J Neurosci Res 1999;58:492-504.
23. Denic A, Bieber A, Warrington A, et al. Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord. Ann Neurol 2009;66:559-64.
24. Lipton HL, Twaddle G, Jelachich ML. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1995;69:2525-33.
25. Tsunoda I, Kuang LQ, Libbey JE, et al. Axonal injury heralds virus-induced demyelination. Am J Pathol 2003;162:1259-69.
26. Tsunoda I. Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future Virol 2008;3:579-93.
27. Tsunoda I, Tanaka T, Saijoh Y, et al. Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 2007;171:1563-75.
28. Deb C, Lafrance-Corey RG, Schmalstieg WF, et al. CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLoS One 2010;5:e12478.